Pharmacotherapy for Cushing disease: a recent Australian experience with osilodrostat

Prishila Fookeerah; Mark McLean

doi:10.1111/imj.16038

Pharmacotherapy for Cushing disease: a recent Australian experience with osilodrostat

Prishila Fookeerah
, Mark McLean

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Cushing disease (CD), hypercortisolism due to an adrenocorticotropic hormone (ACTH)–secreting corticotroph tumour, is a rare condition associated with significant morbidity and mortality. The estimated incidence is 1.6 cases per million population; about 40 cases per year in Australia

Original language	English
Pages (from-to)	451-452
Number of pages	2
Journal	Internal Medicine Journal
Volume	53
Issue number	3
DOIs	https://doi.org/10.1111/imj.16038
Publication status	Published - Mar 2023

Access to Document

10.1111/imj.16038

Cite this

@article{e340550891114814a115c68119fde417,

title = "Pharmacotherapy for Cushing disease: a recent Australian experience with osilodrostat",

abstract = "Cushing disease (CD), hypercortisolism due to an adrenocorticotropic hormone (ACTH)–secreting corticotroph tumour, is a rare condition associated with significant morbidity and mortality. The estimated incidence is 1.6 cases per million population; about 40 cases per year in Australia",

author = "Prishila Fookeerah and Mark McLean",

year = "2023",

month = mar,

doi = "10.1111/imj.16038",

language = "English",

volume = "53",

pages = "451--452",

journal = "Internal Medicine Journal",

issn = "1444-0903",

publisher = "John Wiley and Sons Inc",

number = "3",

}

TY - JOUR

T1 - Pharmacotherapy for Cushing disease

T2 - a recent Australian experience with osilodrostat

AU - Fookeerah, Prishila

AU - McLean, Mark

PY - 2023/3

Y1 - 2023/3

N2 - Cushing disease (CD), hypercortisolism due to an adrenocorticotropic hormone (ACTH)–secreting corticotroph tumour, is a rare condition associated with significant morbidity and mortality. The estimated incidence is 1.6 cases per million population; about 40 cases per year in Australia

AB - Cushing disease (CD), hypercortisolism due to an adrenocorticotropic hormone (ACTH)–secreting corticotroph tumour, is a rare condition associated with significant morbidity and mortality. The estimated incidence is 1.6 cases per million population; about 40 cases per year in Australia

UR - https://www.scopus.com/pages/publications/85150986328

UR - https://go.openathens.net/redirector/westernsydney.edu.au?url=https://doi.org/10.1111/imj.16038

U2 - 10.1111/imj.16038

DO - 10.1111/imj.16038

M3 - Article

C2 - 36972996

AN - SCOPUS:85150986328

SN - 1444-0903

VL - 53

SP - 451

EP - 452

JO - Internal Medicine Journal

JF - Internal Medicine Journal

IS - 3

ER -

Pharmacotherapy for Cushing disease: a recent Australian experience with osilodrostat

Abstract

Access to Document

Other files and links

Fingerprint

Cite this